NASDAQ:CELCCelcuity Stock Price, Forecast & News

$9.27

+0.68 (+7.92 %)

(As of 05/22/2020 04:00 PM ET)

Add

Compare

Today's Range

$8.52

Now: $9.27▼

$9.56

50-Day Range

$5.00

MA: $5.71▼

$9.29

52-Week Range

$4.03

Now: $9.27▼

$25.00

Volume15,570 shs

Average Volume19,349 shs

Market Capitalization$95.11 million

P/E RatioN/A

Dividend YieldN/A

Beta0.73

Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The company's CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELx MP test to diagnose 12 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Beat the Market (BTM) Rank^™

2.5 Analyst's Opinion

Consensus Rating
Celcuity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $11.00, Celcuity has a potential upside of 18.7% from its current price of $9.27.
Amount of Analyst Coverage
Celcuity has only been the subject of 2 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Celcuity has received 295 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Celcuity has received 296 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Celcuity has received 50.08% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Celcuity and other stocks. Vote “Outperform” if you believe CELC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CELC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Celcuity does not currently pay a dividend.
Dividend Growth
Celcuity does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Celcuity insiders have not sold or bought any company stock.
Percentage Held by Insiders
43.50% of the stock of Celcuity is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 22.13% of the stock of Celcuity is held by institutions.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Celcuity are expected to decrease in the coming year, from ($0.81) to ($0.84) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Celcuity is -12.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Celcuity is -12.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Celcuity has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.20 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Medical laboratories

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:CELC

Previous Symbol

CUSIPN/A

CIK1603454

Webwww.celcuity.com

Phone763-392-0767

Debt

Debt-to-Equity RatioN/A

Current Ratio20.16

Quick Ratio20.16

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$1.71 per share

Price / Book5.42

Profitability

EPS (Most Recent Fiscal Year)($0.72)

Net Income$-7,360,000.00

Net MarginsN/A

Return on Equity-38.84%

Return on Assets-37.01%

Miscellaneous

Employees26

Outstanding Shares10,260,000

Market Cap$95.11 million

Next Earnings Date8/13/2020 (Estimated)

OptionableNot Optionable

Receive CELC News and Ratings via Email

Sign-up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

Celcuity (NASDAQ:CELC) Frequently Asked Questions

How has Celcuity's stock been impacted by COVID-19 (Coronavirus)?

Celcuity's stock was trading at $7.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CELC stock has increased by 30.2% and is now trading at $9.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Celcuity?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celcuity in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Celcuity.

When is Celcuity's next earnings date?

Celcuity is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Celcuity.

How were Celcuity's earnings last quarter?

Celcuity Inc (NASDAQ:CELC) announced its earnings results on Thursday, May, 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.02. View Celcuity's earnings history.

What price target have analysts set for CELC?

2 equities research analysts have issued 12 month price objectives for Celcuity's shares. Their forecasts range from $11.00 to $11.00. On average, they expect Celcuity's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price. View analysts' price targets for Celcuity.

Has Celcuity been receiving favorable news coverage?

News coverage about CELC stock has trended very negative on Monday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Celcuity earned a coverage optimism score of -3.9 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutCelcuity.

Are investors shorting Celcuity?

Celcuity saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 64,400 shares, an increase of 21.1% from the April 30th total of 53,200 shares. Based on an average trading volume of 15,100 shares, the short-interest ratio is currently 4.3 days. Approximately 1.3% of the shares of the company are sold short. View Celcuity's Current Options Chain.

Who are some of Celcuity's key competitors?

Some companies that are related to Celcuity include Centogene (CNTG), Fulgent Genetics (FLGT), DermTech (DMTK), Enzo Biochem (ENZ), Anpac Bio-Medical Science (ANPC), Biocept (BIOC), Miragen Therapeutics (MGEN), OpGen (OPGN), Psychemedics (PMD), PotNetwork (POTN), Avant Diagnostics (AVDX), CBA Florida (CBAI), Cancer Genetics (CGIX), First Choice Healthcare Solutions (FCHS) and Aeon Global Health (AGHC). View all competitors.

What other stocks do shareholders of Celcuity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celcuity investors own include Bank of Hawaii (BOH), InterDigital Wireless (IDCC), Stag Industrial (STAG), Evoke Pharma (EVOK), Amicus Therapeutics (FOLD), Allena Pharmaceuticals (ALNA), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Ring Energy (REI) and Ring Energy (REI).

Who are Celcuity's key executives?

Celcuity's management team includes the following people:

Mr. Brian F. Sullivan, Co-Founder, Chairman & CEO (Age 57)
Dr. Lance G. Laing, Co-Founder, Chief Science Officer, VP, Sec. & Director (Age 57)
Ms. Vicky Hahne, Chief Financial Officer (Age 53)
Ms. Laura Beggrow RN, Chief Commercial Officer (Age 56)
Mr. Larry Fitzgerald, VP of Strategic Partnerships & Managed Markets (Age 48)

When did Celcuity IPO?

(CELC) raised $18 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.

What is Celcuity's stock symbol?

Celcuity trades on the NASDAQ under the ticker symbol "CELC."

Who are Celcuity's major shareholders?

Celcuity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Frontier Wealth Management LLC (7.15%), BlackRock Inc. (3.14%), Gagnon Securities LLC (1.92%), State Street Corp (0.87%), UBS Group AG (0.22%) and Wells Fargo & Company MN (0.15%). View institutional ownership trends for Celcuity.

Which major investors are selling Celcuity stock?

CELC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., and Essex Investment Management Co. LLC. View insider buying and selling activity for Celcuity.

Which major investors are buying Celcuity stock?

CELC stock was purchased by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, UBS Group AG, Frontier Wealth Management LLC, Wells Fargo & Company MN, and State Street Corp. View insider buying and selling activity for Celcuity.

How do I buy shares of Celcuity?

Shares of CELC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celcuity's stock price today?

One share of CELC stock can currently be purchased for approximately $9.27.

How big of a company is Celcuity?

Celcuity has a market capitalization of $95.11 million. The company earns $-7,360,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis. Celcuity employs 26 workers across the globe.

What is Celcuity's official website?

The official website for Celcuity is www.celcuity.com.

How can I contact Celcuity?

Celcuity's mailing address is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. The company can be reached via phone at 763-392-0767.

This page was last updated on 5/25/2020 by MarketBeat.com Staff